Anthrax Vaccines Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 110

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

This report contains market size and forecasts of Anthrax Vaccines in US, including the following market information:

US Anthrax Vaccines Market Revenue, 2015-2020, 2021-2026, ($ millions)

US Anthrax Vaccines Market Consumption, 2015-2020, 2021-2026, (M Doses)

US Anthrax Vaccines Production Capacity, 2015-2020, 2021-2026, (M Doses)

Top Five Competitors in US Anthrax Vaccines Market 2019 (%)

The global Anthrax Vaccines market was valued at 603.8 million in 2019 and is projected to reach US$ 799.6 million by 2026, at a CAGR of 7.3% during the forecast period. While the Anthrax Vaccines market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Anthrax Vaccines production and consumption in US

Total Market by Segment:

US Anthrax Vaccines Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Doses)

US Anthrax Vaccines Market Segment Percentages, By Type, 2019 (%)

- Live Vaccines

- Cell free PA Vaccines

US Anthrax Vaccines Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Doses)

US Anthrax Vaccines Market Segment Percentages, By Application, 2019 (%)

- Human Use

- Animal Use

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Anthrax Vaccines Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Anthrax Vaccines Market Competitors Revenues Share in US, by Players 2019 (%)

Total US Anthrax Vaccines Market Competitors Sales, by Players 2015-2020 (Estimated), (M Doses)

Total US Anthrax Vaccines Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

- Emergent BioSolutions

- Merial

- Merck

- Zoetis

- Bayer Sanidad Animal

- Colorado Serum

- PharmAthene

- Tiankang

- Biogénesis-Bago

- CAVAC

- Rosenbusch

- Agrovet

- Vecol

- CVCRI

- IVPM

- Prondil

- CDV

- Indian Immunologicals

- Botswana Vaccine Institute

- Ceva Santé Animale

- Intervac

Anthrax Vaccines Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anthrax Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Anthrax Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: US Anthrax Vaccines Overall Market Size
2.1 US Anthrax Vaccines Market Size: 2020 VS 2026
2.2 US Anthrax Vaccines Revenue, Prospects & Forecasts: 2015-2026
2.3 US Anthrax Vaccines Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Anthrax Vaccines Players in US (including Foreign and Local Companies)
3.2 Top US Anthrax Vaccines Companies Ranked by Revenue
3.3 US Anthrax Vaccines Revenue by Companies (including Foreign and Local Companies)
3.4 US Anthrax Vaccines Sales by Companies (including Foreign and Local Companies)
3.5 US Anthrax Vaccines Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Anthrax Vaccines Companies in US, by Revenue in 2019
3.7 US Manufacturers Anthrax Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in US
3.8.1 List of US Tier 1 Anthrax Vaccines Companies
3.8.2 List of US Tier 2 and Tier 3 Anthrax Vaccines Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Anthrax Vaccines Market Size Markets, 2020 & 2026
4.1.2 Live Vaccines
4.1.3 Cell free PA Vaccines
4.2 By Type - US Anthrax Vaccines Revenue & Forecasts
4.2.1 By Type - US Anthrax Vaccines Revenue, 2015-2020
4.2.2 By Type - US Anthrax Vaccines Revenue, 2021-2026
4.2.3 By Type - US Anthrax Vaccines Revenue Market Share, 2015-2026
4.3 By Type - US Anthrax Vaccines Sales & Forecasts
4.3.1 By Type - US Anthrax Vaccines Sales, 2015-2020
4.3.2 By Type - US Anthrax Vaccines Sales, 2021-2026
4.3.3 By Type - US Anthrax Vaccines Sales Market Share, 2015-2026
4.4 By Type - US Anthrax Vaccines Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Anthrax Vaccines Market Size, 2020 & 2026
5.1.2 Human Use
5.1.3 Animal Use
5.2 By Application - US Anthrax Vaccines Revenue & Forecasts
5.2.1 By Application - US Anthrax Vaccines Revenue, 2015-2020
5.2.2 By Application - US Anthrax Vaccines Revenue, 2021-2026
5.2.3 By Application - US Anthrax Vaccines Revenue Market Share, 2015-2026
5.3 By Application - US Anthrax Vaccines Sales & Forecasts
5.3.1 By Application - US Anthrax Vaccines Sales, 2015-2020
5.3.2 By Application - US Anthrax Vaccines Sales, 2021-2026
5.3.3 By Application - US Anthrax Vaccines Sales Market Share, 2015-2026
5.4 By Application - US Anthrax Vaccines Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Emergent BioSolutions
6.1.1 Emergent BioSolutions Corporate Summary
6.1.2 Emergent BioSolutions Business Overview
6.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings
6.1.4 Emergent BioSolutions Sales and Revenue in US (2015-2020)
6.1.5 Emergent BioSolutions Key News
6.2 Merial
6.2.1 Merial Corporate Summary
6.2.2 Merial Business Overview
6.2.3 Merial Anthrax Vaccines Major Product Offerings
6.2.4 Merial Sales and Revenue in US (2015-2020)
6.2.5 Merial Key News
6.3 Merck
6.3.1 Merck Corporate Summary
6.3.2 Merck Business Overview
6.3.3 Merck Anthrax Vaccines Major Product Offerings
6.3.4 Merck Sales and Revenue in US (2015-2020)
6.3.5 Merck Key News
6.4 Zoetis
6.4.1 Zoetis Corporate Summary
6.4.2 Zoetis Business Overview
6.4.3 Zoetis Anthrax Vaccines Major Product Offerings
6.4.4 Zoetis Sales and Revenue in US (2015-2020)
6.4.5 Zoetis Key News
6.5 Bayer Sanidad Animal
6.5.1 Bayer Sanidad Animal Corporate Summary
6.5.2 Bayer Sanidad Animal Business Overview
6.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings
6.5.4 Bayer Sanidad Animal Sales and Revenue in US (2015-2020)
6.5.5 Bayer Sanidad Animal Key News
6.6 Colorado Serum
6.6.1 Colorado Serum Corporate Summary
6.6.2 Colorado Serum Business Overview
6.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings
6.6.4 Colorado Serum Sales and Revenue in US (2015-2020)
6.6.5 Colorado Serum Key News
6.7 PharmAthene
6.6.1 PharmAthene Corporate Summary
6.6.2 PharmAthene Business Overview
6.6.3 PharmAthene Anthrax Vaccines Major Product Offerings
6.4.4 PharmAthene Sales and Revenue in US (2015-2020)
6.7.5 PharmAthene Key News
6.8 Tiankang
6.8.1 Tiankang Corporate Summary
6.8.2 Tiankang Business Overview
6.8.3 Tiankang Anthrax Vaccines Major Product Offerings
6.8.4 Tiankang Sales and Revenue in US (2015-2020)
6.8.5 Tiankang Key News
6.9 Biogénesis-Bago
6.9.1 Biogénesis-Bago Corporate Summary
6.9.2 Biogénesis-Bago Business Overview
6.9.3 Biogénesis-Bago Anthrax Vaccines Major Product Offerings
6.9.4 Biogénesis-Bago Sales and Revenue in US (2015-2020)
6.9.5 Biogénesis-Bago Key News
6.10 CAVAC
6.10.1 CAVAC Corporate Summary
6.10.2 CAVAC Business Overview
6.10.3 CAVAC Anthrax Vaccines Major Product Offerings
6.10.4 CAVAC Sales and Revenue in US (2015-2020)
6.10.5 CAVAC Key News
6.11 Rosenbusch
6.11.1 Rosenbusch Corporate Summary
6.11.2 Rosenbusch Anthrax Vaccines Business Overview
6.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings
6.11.4 Rosenbusch Sales and Revenue in US (2015-2020)
6.11.5 Rosenbusch Key News
6.12 Agrovet
6.12.1 Agrovet Corporate Summary
6.12.2 Agrovet Anthrax Vaccines Business Overview
6.12.3 Agrovet Anthrax Vaccines Major Product Offerings
6.12.4 Agrovet Sales and Revenue in US (2015-2020)
6.12.5 Agrovet Key News
6.13 Vecol
6.13.1 Vecol Corporate Summary
6.13.2 Vecol Anthrax Vaccines Business Overview
6.13.3 Vecol Anthrax Vaccines Major Product Offerings
6.13.4 Vecol Sales and Revenue in US (2015-2020)
6.13.5 Vecol Key News
6.14 CVCRI
6.14.1 CVCRI Corporate Summary
6.14.2 CVCRI Anthrax Vaccines Business Overview
6.14.3 CVCRI Anthrax Vaccines Major Product Offerings
6.14.4 CVCRI Sales and Revenue in US (2015-2020)
6.14.5 CVCRI Key News
6.15 IVPM
6.15.1 IVPM Corporate Summary
6.15.2 IVPM Anthrax Vaccines Business Overview
6.15.3 IVPM Anthrax Vaccines Major Product Offerings
6.15.4 IVPM Sales and Revenue in US (2015-2020)
6.15.5 IVPM Key News
6.16 Prondil
6.16.1 Prondil Corporate Summary
6.16.2 Prondil Anthrax Vaccines Business Overview
6.16.3 Prondil Anthrax Vaccines Major Product Offerings
6.16.4 Prondil Sales and Revenue in US (2015-2020)
6.16.5 Prondil Key News
6.17 CDV
6.17.1 CDV Corporate Summary
6.17.2 CDV Anthrax Vaccines Business Overview
6.17.3 CDV Anthrax Vaccines Major Product Offerings
6.17.4 CDV Sales and Revenue in US (2015-2020)
6.17.5 CDV Key News
6.18 Indian Immunologicals
6.18.1 Indian Immunologicals Corporate Summary
6.18.2 Indian Immunologicals Anthrax Vaccines Business Overview
6.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings
6.18.4 Indian Immunologicals Sales and Revenue in US (2015-2020)
6.18.5 Indian Immunologicals Key News
6.19 Botswana Vaccine Institute
6.19.1 Botswana Vaccine Institute Corporate Summary
6.19.2 Botswana Vaccine Institute Anthrax Vaccines Business Overview
6.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings
6.19.4 Botswana Vaccine Institute Sales and Revenue in US (2015-2020)
6.19.5 Botswana Vaccine Institute Key News
6.20 Ceva Santé Animale
6.20.1 Ceva Santé Animale Corporate Summary
6.20.2 Ceva Santé Animale Anthrax Vaccines Business Overview
6.20.3 Ceva Santé Animale Anthrax Vaccines Major Product Offerings
6.20.4 Ceva Santé Animale Sales and Revenue in US (2015-2020)
6.20.5 Ceva Santé Animale Key News
6.21 Intervac
6.21.1 Intervac Corporate Summary
6.21.2 Intervac Anthrax Vaccines Business Overview
6.21.3 Intervac Anthrax Vaccines Major Product Offerings
6.21.4 Intervac Sales and Revenue in US (2015-2020)
6.21.5 Intervac Key News
6.22 JOVAC
6.22.1 JOVAC Corporate Summary
6.22.2 JOVAC Anthrax Vaccines Business Overview
6.22.3 JOVAC Anthrax Vaccines Major Product Offerings
6.22.4 JOVAC Sales and Revenue in US (2015-2020)
6.22.5 JOVAC Key News

7 Anthrax Vaccines Production Capacity, Export and Import Analysis
7.1 Anthrax Vaccines Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Anthrax Vaccines Production Capacity, 2015-2026
7.1.2 US Anthrax Vaccines Production 2015-2026
7.1.3 US Anthrax Vaccines Production Value 2015-2026
7.2 Key Local Anthrax Vaccines Manufacturers in US
7.2.1 US Key Local Anthrax Vaccines Manufacturers Production Capacity
7.2.2 US Key Local Anthrax Vaccines Manufacturers Production
7.2.3 US Key Local Anthrax Vaccines Manufacturers Production Value
7.2.4 The Proportion of Anthrax Vaccines Production Sold in US and Sold Other Than US by Manufacturers
7.3 Anthrax Vaccines Export and Import in US
7.3.1 US Anthrax Vaccines Export Market
7.3.2 US Anthrax Vaccines Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Anthrax Vaccines Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Anthrax Vaccines Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Anthrax Vaccines Distributors and Sales Agents in US

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables
Table 1. Key Players of Anthrax Vaccines in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Anthrax Vaccines Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Anthrax Vaccines Revenue Share by Companies, 2015-2020
Table 5. US Anthrax Vaccines Sales by Companies, (M Doses), 2015-2020
Table 6. US Anthrax Vaccines Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Anthrax Vaccines Price (2015-2020) (USD/K Doses)
Table 8. US Manufacturers Anthrax Vaccines Product Type
Table 9. List of US Tier 1 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Anthrax Vaccines Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Anthrax Vaccines Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Anthrax Vaccines Sales in US (M Doses), 2015-2020
Table 14. By Type - Anthrax Vaccines Sales in US (M Doses), 2021-2026
Table 15. By Application - Anthrax Vaccines Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Anthrax Vaccines Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Anthrax Vaccines Sales in US, (M Doses), 2015-2020
Table 18. By Application - Anthrax Vaccines Sales in US, (M Doses), 2021-2026
Table 19. Emergent BioSolutions Corporate Summary
Table 20. Emergent BioSolutions Anthrax Vaccines Product Offerings
Table 21. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 22. Merial Corporate Summary
Table 23. Merial Anthrax Vaccines Product Offerings
Table 24. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 25. Merck Corporate Summary
Table 26. Merck Anthrax Vaccines Product Offerings
Table 27. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 28. Zoetis Corporate Summary
Table 29. Zoetis Anthrax Vaccines Product Offerings
Table 30. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 31. Bayer Sanidad Animal Corporate Summary
Table 32. Bayer Sanidad Animal Anthrax Vaccines Product Offerings
Table 33. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 34. Colorado Serum Corporate Summary
Table 35. Colorado Serum Anthrax Vaccines Product Offerings
Table 36. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 37. PharmAthene Corporate Summary
Table 38. PharmAthene Anthrax Vaccines Product Offerings
Table 39. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 40. Tiankang Corporate Summary
Table 41. Tiankang Anthrax Vaccines Product Offerings
Table 42. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 43. Biogénesis-Bago Corporate Summary
Table 44. Biogénesis-Bago Anthrax Vaccines Product Offerings
Table 45. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 46. CAVAC Corporate Summary
Table 47. CAVAC Anthrax Vaccines Product Offerings
Table 48. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 49. Rosenbusch Corporate Summary
Table 50. Rosenbusch Anthrax Vaccines Product Offerings
Table 51. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 52. Agrovet Corporate Summary
Table 53. Agrovet Anthrax Vaccines Product Offerings
Table 54. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 55. Vecol Corporate Summary
Table 56. Vecol Anthrax Vaccines Product Offerings
Table 57. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 58. CVCRI Corporate Summary
Table 59. CVCRI Anthrax Vaccines Product Offerings
Table 60. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 61. IVPM Corporate Summary
Table 62. IVPM Anthrax Vaccines Product Offerings
Table 63. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 64. Prondil Corporate Summary
Table 65. Prondil Anthrax Vaccines Product Offerings
Table 66. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 67. CDV Corporate Summary
Table 68. CDV Anthrax Vaccines Product Offerings
Table 69. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 70. Indian Immunologicals Corporate Summary
Table 71. Indian Immunologicals Anthrax Vaccines Product Offerings
Table 72. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 73. Botswana Vaccine Institute Corporate Summary
Table 74. Botswana Vaccine Institute Anthrax Vaccines Product Offerings
Table 75. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 76. Ceva Santé Animale Corporate Summary
Table 77. Ceva Santé Animale Anthrax Vaccines Product Offerings
Table 78. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 79. Intervac Corporate Summary
Table 80. Intervac Anthrax Vaccines Product Offerings
Table 81. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 82. JOVAC Corporate Summary
Table 83. JOVAC Anthrax Vaccines Product Offerings
Table 84. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)
Table 85. Anthrax Vaccines Production Capacity (M Doses) of Local Manufacturers in US, 2015-2020
Table 86. Anthrax Vaccines Production (M Doses) of Local Manufacturers in US, 2015-2020
Table 87. US Anthrax Vaccines Production Market Share of Local Manufacturers, 2015-2020
Table 88. Anthrax Vaccines Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 89. US Anthrax Vaccines Production Value Market Share of Local Manufacturers, 2015-2020
Table 90. The Percentage of Anthrax Vaccines Production Sold in US and Sold Other Than US by Manufacturers
Table 91. The Percentage of Anthrax Vaccines Production Sold in US and Sold Other Than US by Manufacturers
Table 92. Dangeguojia Anthrax Vaccines Sales (Consumption), Production, Export and Import, 2015-2020
Table 93. Raw Materials and Suppliers
Table 94. Anthrax Vaccines Downstream Clients in US
Table 95. Anthrax Vaccines Distributors and Sales Agents in US
List of Figures
Figure 1. Anthrax Vaccines Segment by Type
Figure 2. Anthrax Vaccines Segment by Application
Figure 3. Dangeguojia Anthrax Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Anthrax Vaccines Market Size in US, (US$, Mn) & (M Doses): 2020 VS 2026
Figure 6. US Anthrax Vaccines Revenue, 2015-2026 (US$, Mn)
Figure 7. Anthrax Vaccines Sales in US: 2015-2026 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Vaccines Revenue in 2019
Figure 9. By Type - US Anthrax Vaccines Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Anthrax Vaccines Market Share, 2015-2020
Figure 11. By Type - US Anthrax Vaccines Market Share, 2020-2026
Figure 12. By Type - US Anthrax Vaccines Price (USD/K Doses), 2015-2026
Figure 13. By Application - Anthrax Vaccines Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Anthrax Vaccines Market Share, 2015-2020
Figure 15. By Application - US Anthrax Vaccines Market Share, 2020-2026
Figure 16. By Application -US Anthrax Vaccines Price (USD/K Doses), 2015-2026
Figure 17. US Anthrax Vaccines Production Capacity (M Doses), 2015-2026
Figure 18. US Anthrax Vaccines Actual Output (M Doses), 2015-2026
Figure 19. US Anthrax Vaccines Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Anthrax Vaccines Export Destination, 2019
Figure 21. The Source of Imports of US Anthrax Vaccines, 2019
Figure 22. PEST Analysis for US Anthrax Vaccines Market in 2020
Figure 23. Anthrax Vaccines Market Opportunities & Trends in US
Figure 24. Anthrax Vaccines Market Drivers in US
Figure 25. Anthrax Vaccines Market Restraints in US
Figure 26. Anthrax Vaccines Industry Value Chain
  • Global POC Infectious Diseases Market Size, Status and Forecast 2020-2026
    Published: 10-Jul-2020        Price: US 3900 Onwards        Pages: 94
    POC Infectious Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Abbott - Meridian Bioscience - Orasu......
  • Global Photomedicine Market Size, Status and Forecast 2020-2026
    Published: 10-Jul-2020        Price: US 3900 Onwards        Pages: 133
    Photomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Photomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Beurer - Koninklijke Philips - Lumie - Verilux......
  • Global Pediatric Medicines Market Insights and Forecast to 2026
    Published: 10-Jul-2020        Price: US 3900 Onwards        Pages: 114
    Pediatric Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Pediatric Medicines market is segmented into - Enteral - Parenteral - Topical ......
  • Global Melatonin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 10-Jul-2020        Price: US 5900 Onwards        Pages: 118
    Melatonin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Melatonin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Melatonin market is segmented into ......
  • COVID-19 Outbreak-Global Lincomycin Hcl Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 108
    The Lincomycin Hcl market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry.Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry deve......
  • COVID-19 Outbreak-Global Hirudin Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 09-Jul-2020        Price: US 3660 Onwards        Pages: 107
    Hirudin is a naturally occurring peptide in the salivary glands of blood-sucking leeches that has a blood anticoagulant property.This is fundamental for the leeches' alimentary habit of hematophagy, since it keeps the blood flowing after the initial phlebotomy performed by the worm on the host's skin.The Hirudin market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report......
  • 2015-2025 Global Polio Vaccine Market Research by Type, End-Use and Region (COVID-19)
    Published: 09-Jul-2020        Price: US 2900 Onwards        Pages: 100
    Summary Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth. The global Polio Vaccine market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Mark......
  • Global Meningitis Vaccine Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 09-Jul-2020        Price: US 3200 Onwards        Pages: 177
    According to HJ Research's study, the global Meningitis Vaccine market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Meningitis Vaccine market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 2020 ......
  • Global Eprosartan Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 09-Jul-2020        Price: US 3200 Onwards        Pages: 159
    According to HJ Research's study, the global Eprosartan market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Eprosartan market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 2020 to 2026 as the f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs